Exchange: NASDAQ·Updated 05:31 AM EDT
ASBP logo

ASBPAspire Biopharma Holdings Inc

$7.03
$0.215
(2.97%)
Pre-Market
Prev Close $7.25
Mkt Cap$9.03M
Vol145.00
News
all
press releases
ASBP Stock Heads For Best Week In Over 2 Months – Why This Drug Delivery Tech Firm Is Buying An Auto Supplier?
The company announced the acquisition of Dura Driver Control Systems for $30 million in cash.
Stocktwits
More News
Healthcare Disruption, AI Biologics, and Wall Street Upgrades Ignite a Midday Market Surge
Healthcare innovators are pushing the markets today. $TGNT, $AGL, $ATRA, $ASBP
24-7 Market News
ASBP Stock Jumps 21% On Buyback Offer – Retail Believes Every Dip’s A Buying Opportunity
Aspire Biopharma’s board approved a share repurchase program of up to $5 million, which will be funded from existing cash.
Stocktwits
ASBP Bulls Back In Control After 78% Crash: What Changed?
The company closed a $21 million private placement that lifted its shareholders’ equity above Nasdaq’s minimum listing requirement.
Stocktwits
LCID, ASBP, WLDS Stocks Hit 52-Week Lows: What Drove The Selloff?
The declines came amid leadership uncertainty, financing concerns, and downward revisions in price targets from Wall Street analysts.
Stocktwits
LCID, ABT, ASBP Stocks Hit 52-Week Lows Today: What’s Driving The Selloff?
LCID and ABT each fell about 6% on Thursday, while ASBP plunged 45%, bucking a broader market rally.
Stocktwits
ASBP Stock Soars 32% After Favorable Feedback From FDA For Its Aspirin –  Retail Expects Licensing Negotiations Soon
The FDA’s feedback supports a planned new drug application submission in the second half of 2026.
Stocktwits
<
1
>

Advertisement|Remove ads.